Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

US physicians eagerly await approval of new HCV drugs

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    US physicians eagerly await approval of new HCV drugs. Pharmacoecon. Outcomes News 616, 11 (2010). https://doi.org/10.2165/00151234-201006160-00038

    Download citation

    Keywords

    • Hepatitis
    • Outcome News
    • Online Survey
    • Rate Efficacy
    • Telaprevir